MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects
Juliette Coursimault,Anne-Marie Guerrot,Michelle M Morrow,Catherine Schramm,Francisca Millan Zamora,Anita Shanmugham,Shuxi Liu,Fanggeng Zou,Frédéric Bilan,Gwenaël Le Guyader,Ange-Line Bruel,Anne-Sophie Denommé-Pichon,Laurence Faivre,Frédéric Tran Mau-Them,Marine Tessarech,Estelle Colin,Salima El Chehadeh,Bénédicte Gérard,Elise Schaefer,Benjamin Cogne,Bertrand Isidor,Mathilde Nizon,Diane Doummar,Stéphanie Valence,Delphine Héron,Boris Keren,Cyril Mignot,Charles Coutton,Françoise Devillard,Anne-Sophie Alaix,Jeanne Amiel,Laurence Colleaux,Arnold Munnich,Karine Poirier,Marlène Rio,Sophie Rondeau,Giulia Barcia,Bert Callewaert,Annelies Dheedene,Candy Kumps,Sarah Vergult,Björn Menten,Wendy K Chung,Rebecca Hernan,Austin Larson,Kelly Nori,Sarah Stewart,James Wheless,Christina Kresge,Beth A Pletcher,Roseline Caumes,Thomas Smol,Sabine Sigaudy,Christine Coubes,Margaret Helm,Rosemarie Smith,Jennifer Morrison,Patricia G Wheeler,Amy Kritzer,Guillaume Jouret,Alexandra Afenjar,Jean-François Deleuze,Robert Olaso,Anne Boland,Christine Poitou,Thierry Frebourg,Claude Houdayer,Pascale Saugier-Veber,Gaël Nicolas,François Lecoquierre
DOI: https://doi.org/10.1007/s00439-021-02383-z
Abstract:Pathogenic variants of the myelin transcription factor-1 like (MYT1L) gene include heterozygous missense, truncating variants and 2p25.3 microdeletions and cause a syndromic neurodevelopmental disorder (OMIM#616,521). Despite enrichment in de novo mutations in several developmental disorders and autism studies, the data on clinical characteristics and genotype-phenotype correlations are scarce, with only 22 patients with single nucleotide pathogenic variants reported. We aimed to further characterize this disorder at both the clinical and molecular levels by gathering a large series of patients with MYT1L-associated neurodevelopmental disorder. We collected genetic information on 40 unreported patients with likely pathogenic/pathogenic MYT1L variants and performed a comprehensive review of published data (total = 62 patients). We confirm that the main phenotypic features of the MYT1L-related disorder are developmental delay with language delay (95%), intellectual disability (ID, 70%), overweight or obesity (58%), behavioral disorders (98%) and epilepsy (23%). We highlight novel clinical characteristics, such as learning disabilities without ID (30%) and feeding difficulties during infancy (18%). We further describe the varied dysmorphic features (67%) and present the changes in weight over time of 27 patients. We show that patients harboring highly clustered missense variants in the 2-3-ZNF domains are not clinically distinguishable from patients with truncating variants. We provide an updated overview of clinical and genetic data of the MYT1L-associated neurodevelopmental disorder, hence improving diagnosis and clinical management of these patients.